Trial Profile
Public-interest Multicenter Umbrella Trial Based on Genetic Analysis in Korean Head and Neck Cancer and Esophageal Cancer Patient - Part 1 (HNSCC)]
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Oct 2017
At a glance
- Drugs Abemaciclib (Primary) ; Alpelisib (Primary) ; Durvalumab (Primary) ; Nintedanib (Primary) ; Poziotinib (Primary) ; Tremelimumab (Primary)
- Indications Head and neck cancer; Nasopharyngeal cancer; Oesophageal cancer; Squamous cell cancer
- Focus Biomarker; Therapeutic Use
- 27 Sep 2017 New trial record